As of June 16, 2025, Genocea Biosciences Inc (GNCA) reports a Graham Number of 2.42.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Comparing Genocea Biosciences Inc's Graham Number to Peers
To better understand Genocea Biosciences Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Genocea Biosciences Inc (GNCA) | 2.42 |
| Regeneron Pharmaceuticals Inc (REGN) | 500.00 |
| Moderna Inc (MRNA) | 157.32 |
| Vertex Pharmaceuticals Inc (VRTX) | 146.93 |
| Amgen Inc (AMGN) | 43.25 |
| Sierra Oncology Inc (SRRA) | 18.52 |
Compared to its competitors, Genocea Biosciences Inc's Graham Number is about average compared to peers, reflecting standard fundamental metrics for the industry.